Endurance RP stock analysis
Want to see HK:0575 full AI Analyst Report?
Endurance RP (0575) Stock Price & Analysis
0575 Stock Chart & Stats
- Day’s Range
- HKD 0.79 - HKD 0.87
- 52-Week Range
- HKD 0.57 - HKD 1.22
- Previous Close
- HKD 0.85
- Volume
- N/A
- Average Volume (3M)
- 50.33K
- Market Cap
- HKD 246.58M
- Enterprise Value
- HKD 359.35M
- Total Cash (Recent Filing)
- HKD 255.96K
- Total Debt (Recent Filing)
- HKD 7.36M
- Price to Earnings (P/E)
- ―
- Beta
- 0.69
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Feb 08, 2013
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
High 2025 Gross Margin
The strong 2025 gross margin indicates that the company can retain substantial value after direct costs when revenue is generated. If sustained and paired with better operating discipline, this could support improved profitability, although past inconsistency limits confidence in its durability.
Improving Free Cash Flow
The year-over-year improvement in free cash flow suggests some progress in cash management or operating performance. It does not yet represent self-funding because cash flow remains negative, but continued improvement could reduce the pace of cash burn and support greater financial resilience.
Reported EPS Growth
The reported positive EPS-growth metric provides evidence of improvement in per-share earnings relative to the comparison period. However, it should be interpreted cautiously because the company remains loss-making, so the benefit is not yet equivalent to durable positive earnings generation.
Bears Say
Deteriorating Profitability
Deepening losses and negative operating earnings show that the business is not converting its revenue base into sustainable profitability. This weakens internal funding capacity and makes future earnings dependent on a meaningful improvement in operating performance rather than gross-margin strength alone.
Revenue Volatility
Large revenue fluctuations reduce visibility into the company’s underlying demand and make staffing, investment, and cash planning more difficult. The sharp 2025 decline also increases the risk that any reported margin or earnings improvement will prove difficult to sustain across future periods.
Negative Equity And Leverage
Negative equity materially limits financial flexibility and indicates that liabilities exceed the recorded asset base. Debt that is large relative to assets heightens refinancing risk and can constrain capital allocation, leaving less capacity to absorb losses or fund recovery internally.
0575 FAQ
What was Endurance RP’s price range in the past 12 months?
What is Endurance RP’s market cap?
When is Endurance RP’s upcoming earnings report date?
How were Endurance RP’s earnings last quarter?
Is Endurance RP overvalued?
Does Endurance RP pay dividends?
What is Endurance RP’s EPS estimate?
How many shares outstanding does Endurance RP have?
What happened to Endurance RP’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Endurance RP?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Endurance RP
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Jamie Alexander Gibson
- Employees
- 17
- Website
- www.regentpac.com
- Address
- HK
Endurance RP (0575) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 6 | 7 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 8 | 0 | 4 |









